These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1647570

  • 1. Meta-analysis of quinolone-theophylline interactions.
    Parent M, LeBel M.
    DICP; 1991 Feb; 25(2):191-4. PubMed ID: 1647570
    [Abstract] [Full Text] [Related]

  • 2. Overview of the fluoroquinolone antibiotics.
    Just PM.
    Pharmacotherapy; 1993 Feb; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [Abstract] [Full Text] [Related]

  • 3. Drug-drug interactions affecting fluoroquinolones.
    Wijnands GJ, Vree TB, Janssen TJ, Guelen PJ.
    Am J Med; 1989 Dec 29; 87(6C):47S-51S. PubMed ID: 2603893
    [Abstract] [Full Text] [Related]

  • 4. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
    Sarkar M, Polk RE, Guzelian PS, Hunt C, Karnes HT.
    Antimicrob Agents Chemother; 1990 Apr 29; 34(4):594-9. PubMed ID: 2344166
    [Abstract] [Full Text] [Related]

  • 5. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB, Swanson RN.
    Drugs Exp Clin Res; 1988 Apr 29; 14(6):375-8. PubMed ID: 3145851
    [Abstract] [Full Text] [Related]

  • 6. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
    Staib AH, Harder S, Fuhr U, Wack C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun 29; 27(6):289-3. PubMed ID: 2737798
    [Abstract] [Full Text] [Related]

  • 7. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Schmid DA, Depta JP, Pichler WJ.
    Clin Exp Allergy; 2006 Jan 29; 36(1):59-69. PubMed ID: 16393267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 4-quinolones inhibit biotransformation of caffeine.
    Harder S, Staib AH, Beer C, Papenburg A, Stille W, Shah PM.
    Eur J Clin Pharmacol; 1988 Jan 29; 35(6):651-6. PubMed ID: 2853056
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
    Ono C, Tanaka M.
    J Pharm Pharmacol; 2003 Aug 29; 55(8):1127-33. PubMed ID: 12956903
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Drug-drug interactions with fluoroquinolones.
    Marchbanks CR.
    Pharmacotherapy; 1993 Aug 29; 13(2 Pt 2):23S-28S. PubMed ID: 8474934
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS, Talboys CA, Roberts AP.
    J Chemother; 1989 Jul 29; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract] [Full Text] [Related]

  • 20. Photocleavage of DNA by the fluoroquinolone antibacterials.
    Martínez L, Chignell CF.
    J Photochem Photobiol B; 1998 Aug 21; 45(1):51-9. PubMed ID: 9819899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.